A lipid droplet-targetable and biothiol-sensitive fluorescent probe for the diagnosis of cancer cells/tissues

Yuewei Zhang1, Ning Zhang1,2, Shuohang Wang1

  • 1School of Chemistry and Pharmaceutical Engineering, Jilin Institute of Chemical Technology, Jilin, 132022, P. R. China. dongjibinghuayuxue@163.com.

The Analyst
|March 25, 2022
PubMed

Insights

Researchers developed BTDA-RSS, a fluorescent probe that targets lipid droplets (LDs) and detects biothiols. This tool successfully distinguishes cancer cells and tissues, offering potential for clinical cancer diagnosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Lipid droplets (LDs) are increasingly recognized as crucial in cancer development, resistance, and treatment.
  • The role of biothiols within LDs in cancer remains largely unexplored due to a lack of suitable detection tools.

Purpose of the Study:

  • To develop a novel fluorescent probe for targeting LDs and sensing biothiols.
  • To investigate the potential of this probe for cancer diagnosis by imaging biothiol level changes in LDs.

Main Methods:

  • Synthesis of a LD-targetable, biothiol-sensitive fluorescent probe (BTDA-RSS) incorporating a 2,4-dinitrobenzenesulfonyl (DNBS) group.
  • Evaluation of the probe's fluorescence response to biothiols and its ability to target LDs.
  • Application of the probe for imaging biothiol variations in cancer cells, tissues, and patient surgical specimens.

Main Results:

  • BTDA-RSS exhibited a rapid, 'turn-on' fluorescence response upon reaction with biothiols via DNBS cleavage.
  • The probe demonstrated effective targeting of LDs and successful imaging of endogenous and exogenous biothiol changes.
  • BTDA-RSS clearly differentiated cancerous cells and tissues from normal ones, showing high contrast.

Conclusions:

  • BTDA-RSS is an effective tool for visualizing biothiol dynamics in LDs.
  • The probe's ability to distinguish cancerous from normal samples highlights its potential for clinical cancer diagnosis.
  • This study provides the first visualization of LD biothiols in human cancer surgical specimens, paving the way for new diagnostic applications.